CDEK
← All organizations

Avadel Pharmaceuticals

For profitContributed to NMEWebsite ↗

Also known as: Avadel | AVADEL CNS | AVADEL LEGACY | AVADEL SPECLT

Phase 1Phase 2Phase 3Phase 4

First clinical trial

Jun 12, 2020

First marketed drug

May 3, 2013

First NDA

May 3, 2013

Last known activity

Feb 28, 2025

Acquired by Alkermes on Nov 19, 2025

Timeline

1990s

  1. Jun 1, 1990

    Avadel Pharmaceuticals— Founded

2010s

  1. May 3, 2013

    neostigmine— NDA Organization

  2. Jun 27, 2014

    phenylephrine— NDA Secondary Org

  3. Apr 29, 2016

    ephedrine— Marketing Organization

  4. Jan 1, 2017

    Flamel Technologies— Acquired

2020s

  1. Nov 19, 2025

    Alkermes— Acquired By

Drugs by trial phase (6 distinct, 9 trials)

Phase 3 (0 own, 1 via acquisition)

Phase 2 (0 own, 5 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (6)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (3)

Details

Founded
Dublin, IE Jun 1, 1990
First NDA
May 3, 2013
Last known activity
Feb 28, 2025